Abstract
Malignant gliomas are the most common brain tumor in adults. Each year, more than 14,000 new cases are diagnosed in the USA. Glioblastomas account for approximately 60–70% of malignant gliomas, anaplastic astrocytomas for 10–15%, and anaplastic oligodendrogliomas, anaplastic oligoastrocytomas, and less common tumors such as anaplastic ependymomas and anaplastic gangliogliomas account for the rest (Primary Brain Tumors in the United States Statistical Report 2007–2008).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Brem H, Piantadosi S, Burger PC et al (1995) Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas: the polymer-brain tumor treatment group. Lancet 345:1008–1012
Burger PC, Dubois PJ, Schold SC et al (1983) Computerized tomographic and pathologic studies of the untreated, quiescent and recurrent glioblastoma multiforme. J Neurosurg 58:159–169
Butowski NA, Sneed PK, Chang SM (2006) Diagnosis and treatment of recurrent high-grade astrocytoma. J Clin Oncol 24:1273–1280
Cho KH, Hall WA, Gerbi BJ et al (1999) Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys 45:1133–1141
Combs SE, Widmer V, Thilmann C et al (2005) Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM). Cancer 104:2168–2173
Filippini G, Falcone C, Boiardi A et al (2008) Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro Oncol 10:79–87
Fisher PG, Buffler PA (2005) Malignant gliomas in 2005: where to go from here? JAMA 293:615–617
Glass J, Silverman CL, Axelrod R et al (1997) Fractionated stereotactic radiosurgery with cis-platinum radiosensitization in the treatment of recurrent, progressive, or persistent malignant astrocytoma. Am J Clin Oncol 20:226–229
Hess CF, Schaaf JC, Kortmann RD et al (1994) Malignant glioma: patterns of failure following individually tailored limited volume irradiation. Radiother Oncol 30:146–149
Hudes RS, Corn BW, Werner-Wasik M et al (1999) A Phase I dose escalation study of hypofractionated stereotactic radiosurgery as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys 43:293–298
Kondziolka D, Flickinger JC, Bissonette DJ et al (1997) Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 41:776–783
Kong D, Lee J, Park K et al (2007) Efficiency of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas. Cancer 112:2046–2051
Lamba M, Breneman JC, Warnick RE (2009) Evaluation of image-guided positioning for frameless intracranial radiosurgery. Int J Radiat Oncol Biol Phys 1(74):913–919
Lederman G, Wronski M, Arbit E et al (2000) Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel. Am J Clin Oncol 23:155–159
Primary Brain Tumors in the United States Statistical Report (2007–2008) http://www.cbtrus.org/reports/2007-2008/2007report.pdf (accessed September 18, 2008)
Schiff D (2007) Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation. Cancer Invest 25(8): 776–784
Schwer AL, Damek DM, Kavanagh BD et al (2008) A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 70: 993–1001
Schwer A, Kavanagh B, McCammon R et al (2009) Radiographic and histopathologic observations after combined EGFR inhibition and hypofractionated stereotactic radiosurgery in Patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 73:1352–1357
Shaw E, Kline R, Gillin M et al (1993) Radiation Therapy Oncology Group: radiosurgery quality assurance guidelines. Int J Radiat Oncol Biol Phys 27:1231–1239
Shaw E, Scott C, Souhami L et al (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47:291–298
Shepherd SF, Laing RW, Cosgrove VP et al (1997) Hypofractionated stereotactic radiosurgery in the management of recurrent glioma. Int J Radiat Oncol Biol Phys 37:393–398
Shrieve DC, Alexander E III, Wen PY et al (1995) Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 36:275–282
Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996
Stupp R, Hegi ME, van den Bent MJ et al (2006) Changing paradigms – an update on the multidisciplinary management of malignant glioma. Oncologist 11(2):165–180
Wong ET, Hess KR, Gleason MJ et al (1999) Outcomes and prognostic factors in recurrent glioma patients enrolled onto Phase II clinical trials. J Clin Oncol 17:2572–2579
Wurm RE, Kuczer DA, Schlenger L et al (2006) Hypofractionated stereotactic radiosurgery combined with topotecan in recurrent malignant glioma. Int J Radiat Oncol Biol Phys 66(Suppl 4):S26–S32
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Chen, C. (2011). Recurrent Malignant Gliomas. In: De Salles, A., et al. Shaped Beam Radiosurgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11151-8_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-11151-8_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-11150-1
Online ISBN: 978-3-642-11151-8
eBook Packages: MedicineMedicine (R0)